Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Groundbreaking Laser-Driven X-Ray Generation Technology to Advance Diagnostic Imaging

By HospiMedica International staff writers
Posted on 30 Dec 2021

A new groundbreaking technology that uses ultrafast lasers to generate ultrabrilliant pulsed X-rays could accelerate research and advance diagnostic imaging. More...

Research Instruments Corporation (Providence, RI, USA) has been named a 2022 Prism Awards Finalist for its Laser Plasma X-ray Source LPXS that uses ultrafast lasers to generate ultrabrilliant pulsed X-rays to accelerate research and advance diagnostic imaging.

"Wilhelm Roentgen's Nobel Prize-winning X-ray invention hasn't changed significantly in more than a century," said Dr. Christoph Rose-Petruck, Ph.D., co-inventor and Chief Science Officer. "Today we usher in a new age of X-ray generation by turning a laser-induced plasma into a very large X-ray flux emitted from a microscopic spot to deliver ultra-brilliant picosecond pulsed X-rays beyond conventional X-ray tube limits."

"Our novel Laser Plasma X-ray Source will bring life-saving ultra-high-resolution capabilities to diagnostic imaging. Our Phase Contrast Imaging technique can achieve more than a 20X resolution improvement in X-ray mammography with 95% less X-ray radiation. Beyond medical devices, we can address a vast research and industrial application landscape, including enabling time-resolved experiments such as turbulent flow analysis and protein folding experiments that were previously in the sole domain of large user facilities such as synchrotrons."

"X-ray sources have been the backbone of analytical instruments and medical devices solving fundamental problems for more than one hundred years," said Daniel DeCiccio, Chief Technology Officer. "We overcome limitations of X-ray tubes that either had high X-ray power with poor spatial resolution, or provided adequate spatial resolution, but with very little X-ray power. Now, thanks to ultrafast industrial lasers, we can deliver higher X-ray power, excellent spatial resolution, and ultrashort X-ray pulses all from a compact bench-scale X-ray source," he said.

"Our laser-driven X-ray platform brings new capabilities to the global X-ray application arena expected to exceed USD 100 billion by 2026, spanning diagnostic imaging, industrial testing, quality control, security, materials research, life sciences, and more," said Keith Bisogno, Chief Business Officer.

Related Links:
Research Instruments Corporation 


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Silver Member
ECG Management System
NEMS Web
Infant Incubator
OKM 801
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.